Elsevier

The Lancet

Volume 355, Issue 9210, 1 April 2000, Pages 1158-1159
The Lancet

Research Letters
Survival after introduction of HAART in people with known duration of HIV-1 infection

https://doi.org/10.1016/S0140-6736(00)02069-9Get rights and content

Summary

We compared survival from HIV-1 seroconversion before and during the periods of highly-active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV-1-infected individuals in 1997–98 (HAART period) compared with those in 1986–96 (pre-HAART period). Estimated survival 10 years from seroconversion was also substantially better in the later period.

References (4)

There are more references available in the full text version of this article.

Cited by (198)

  • Ocular syphilis

    2022, Survey of Ophthalmology
  • Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity

    2019, Vascular Pharmacology
    Citation Excerpt :

    However, these characteristics were attenuated following Saroglitazar co-treatment with HAART in obese animals. Current trends indicate that non-AIDS-related cardiometabolic events are emerging as a major health burden in HIV-infected populations [36]. The pathophysiological mechanisms underlying these events are still incompletely understood because specific organ disturbances are multifactorial in aetiology.

  • Optimal timing for elective total hip replacement in HIV-positive patients

    2018, Orthopaedics and Traumatology: Surgery and Research
  • Knee extension and flexion strength asymmetry in Human Immunodeficiency Virus positive subjects: a cross-sectional study

    2017, Brazilian Journal of Physical Therapy
    Citation Excerpt :

    The human immunodeficiency virus (HIV) attacks the immune system of its host and may cause acquired immunodeficiency syndrome (AIDS). However, the course of the HIV infection changed dramatically with the introduction of highly active antiretroviral therapy (HAART), which reduced patient mortality and morbidity and transitioned AIDS from an acute to a chronic disease.1 In a 2010 study, an examination of the specific causes of mortality in HIV-positive patients found that only 49.5% of deaths were AIDS-related, and the proportion of deaths classified as AIDS-related decreased with increasing duration of HAART.2

View all citing articles on Scopus
View full text